China Money Network
Login
Join

Chinese Drug Maker Thousand Oaks Biopharmaceuticals Nets $44M In Series A Round

  • January 2, 2019 — 15:53 CST

This Data Is Locked!

This area is available only to Subscribers.

Chinese therapeutics medicine developer Thousand Oaks Biopharmaceuticals Co. announced yesterday that they have completed a RMB300 million (US$43.61 million) series A round of financing, led... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: